middle.news
How AVITA Medical’s Q2 Revenue Growth Masks Looming Liquidity Risks
1:32pm on Friday 8th of August, 2025 AEST
•
Healthcare
Read Story
How AVITA Medical’s Q2 Revenue Growth Masks Looming Liquidity Risks
1:32pm on Friday 8th of August, 2025 AEST
Key Points
21% revenue growth to $18.4 million in Q2 2025
Net loss narrowed to $9.9 million for the quarter
Gross margin pressured by volume discounts and product mix
Loan covenant breaches led to waivers and amended credit terms
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avita Medical (ASX:AVH)
OPEN ARTICLE